Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2000 participants
OBSERVATIONAL
2017-01-31
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Indication: Which are the different indications for cardiac surgical ablation in patients with atrial fibrillation?
* How often and in which patients the different concepts of surgery and ablation procedures are used? At the same time, how often an intervention at the left atrial appendage is carried out?
* Safety: How secure is the cardiac surgical ablation of atrial fibrillation (periprocedural, during hospital stay and during the long-term follow up)?
* Effectiveness: How effectively is the cardiac surgical ablation of atrial fibrillation (procedural success)? How often are AF recurrences in the long-term follow up?
* What is the concommitant medical treatment after surgical ablation?
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Treated by cardiac surgical ablation
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stiftung Institut fuer Herzinfarktforschung
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thorsten Hanke, MD
Role: PRINCIPAL_INVESTIGATOR
Asklepios Hamburg Harburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinikum Bogenhausen
München, Bavaria, Germany
Asklepios Harburg
Hamburg, Hamburg, Germany
Schüchtermann Kliniken
Bad Rothenfelde, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Edgar Eszlari, MD
Role: primary
Thorsten Hanke, MD
Role: primary
Jürgen Ackemann, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CASE-AF
Identifier Type: -
Identifier Source: org_study_id